Showing results (2111-2120 of 9,904) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|April 26, 2016
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphomaS Hong, L Rybicki, D M Abounader, et al.
Bone Marrow Transplantation|April 19, 2016
A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategyM Martino, G Tripepi, G Messina, et al.
Bone Marrow Transplantation|April 19, 2016
Prognostic factors and outcomes for pediatric patients receiving an haploidentical relative allogeneic transplant using CD3/CD19-depleted graftsM A Diaz, A Pérez-Martínez, B Herrero, et al.
Bone Marrow Transplantation|July 25, 2017
Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot studyL M Bezinelli, F P Eduardo, D L C de Carvalho, et al.
Bone Marrow Transplantation|July 18, 2017
Impact of molecular residual disease post allografting in myelofibrosis patientsC Wolschke, A Badbaran, T Zabelina, et al.
Bone Marrow Transplantation|August 8, 2017
Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantationM Ogata, K Oshima, T Ikebe, et al.
Bone Marrow Transplantation|October 24, 2017
Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategiesS M Rubinstein, K A Culos, B Savani, et al.
Bone Marrow Transplantation|November 14, 2017
Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impactM R Dowling, S Li, B R Dey, et al.
Bone Marrow Transplantation|November 14, 2017
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Bone Marrow Transplantation|September 5, 2017
Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndromeD Modi, A Deol, S Kim, et al.
Pageof 991